Global Patent Ductus Arteriosus Treatment Market, By Diagnosis (Eechocardiogram, Chest X ray, Electrocardiogram and Others), Treatment (Medicines, Catheter Based Procedures and Surgery), End-Users (Hospitals, Homecare, Speciality Centres, Others), Distribution Channel (Hospital Pharmacy, Online Pharmacy, Retail Pharmacy) – Industry Trends and Forecast to 2030.
Patent Ductus Arteriosus Treatment Market Analysis and Size
The incidence of infants with patent ductus arteriosus was 81 per 10,000 live births and 45.2% in very low birth weight (VLBW) infants, which increased from 2015 to 2018. Surgical treatment had a considerably higher risk of mortality than conservative treatment. Surgical or medical treatments were related with a increased risk of morbidity. Increased use of conservative management of patent ductus arteriosus has improved neonatal outcomes in VLBW infants.
Data Bridge Market Research analyses a growth rate in the patent ductus arteriosus market in the forecast period 2023-2030. The expected CAGR of the patent ductus arteriosus market patent ductus arteriosus treatment market tends to be around 15% in the mentioned forecast period. The market was valued at USD 2.4 billion in 2022 and would grow to USD 7.34 billion by 2030. In addition to the market insights such as market value, growth rate, market segments, geographical coverage, market players, and market scenario, the market report curated by the Data Bridge Market Research team also includes in-depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.
Patent Ductus Arteriosus Treatment Market Scope and Segmentation
|
Report Metric
|
Details
|
|
Forecast Period
|
2023 to 2030
|
|
Base Year
|
2022
|
|
Historic Years
|
2021(Customizable to 2015 - 2020)
|
|
Quantitative Units
|
Revenue in USD Million, Volumes in Units, Pricing in USD
|
|
Segments Covered
|
Diagnosis (Eechocardiogram, Chest X ray, Electrocardiogram and Others), Treatment (Medicines, Catheter Based Procedures and Surgery), End-Users (Hospitals, Homecare, Speciality Centres, Others), Distribution Channel (Hospital Pharmacy, Online Pharmacy, Retail Pharmacy)
|
|
Countries Covered
|
U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America
|
|
Market Players Covered
|
Merck & Co., Inc. (U.S.), AstraZeneca (U.K.), KYOWA PHARMA CHEMICAL CO.,LTD. (Japan), Sanofi (France), GSK plc (U.K.), Johnson & Johnson Private Limited (U.S.), Pfizer Inc (U.S.)
|
|
Market Opportunities
|
|
Market Definition
A patent ductus arteriosus is a type of condition characterised as a heart problem that generally occurs after birth in the children. The abnormal blood flow mainly occurs in patent ductus arteriosus condition between the major arteries that are connected to the heart. The ductus arteriosus remains open and this opening allows the oxygen-rich blood from the aorta to amalgamate with oxygen-poor blood from the pulmonary artery. This can put strain on the heart and increase the blood pressure in the lung arteries. The major symptoms includes fast breathing, sweating with exertion, tiredness, and shortness of breath.
Patent Ductus Arteriosus Treatment Market Dynamics
Drivers
- Increasing Demand for Diagnostic Tests
The rising demand for diagnostic tests such as echocardiogram boosts market growth. In this test, sound waves produce images of the heart which can help the doctor identify the disease and check how well the heart is pumping. This test also helps the doctor assess the heart valves and detect other potential heart defects
- Rise in the Number of R&D Activities
An increase in the number of R&D activities push the market growth. This will provide numerous beneficial opportunities for the market. The government funds multiple research and development (R&D) initiatives to motivate researchers and pharmaceutical companies to develop novel medicines.
Opportunities
- Introduction of Diversified Treatment Methods
The increasing introduction of varied treatment methods such as conservative treatment, intravenous ibuprofen, surgery, and oral ibuprofen creates more opportunities for market growth by increasing the patient recovery.
- Increasing Demand for Retail Pharmacies
The growth in the number of drugs for patent ductus arterios that is delivered through retail pharmacies and the surge in the number of pharmacies in several developed countries create opportunities for market growth. Moreover, patients prefer retail pharmacies for purchasing drugs, as these are easily viable.
Restraints/Challenges
- Lack of Skilled Professionals
A lack of trained professionals who are unaware of the treatment methods for this disease could limit the growth of the patent ductus arteriosus treatment market during the forecast period.
- Unavailability of Appropriate Treatments
To treat rare conditions, treatments are sometimes not available, particularly in underdeveloped countries, even for these conditions. Some conditions demand to be treated with advanced techniques, but these are sometimes unavailable in hospitals and clinics. Thus, it hampers market growth.
This patent ductus arteriosus treatment market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the patent ductus arteriosus treatment market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
Global Patent Ductus Arteriosus Treatment Market Scope
The patent ductus arteriosus treatment market is segmented on the basis of diagnosis, treatment, distribution channel and end-user. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.
Diagnosis
- Eechocardiogram
- Chest X ray
- Electrocardiogram
- Others
Treatment
- Medicines
- Catheter Based Procedures
- Surgery
End-Users
- Hospitals
- Homecare
- Speciality Centres
- Others
Distribution Channel
- Hospital Pharmacy
- Online Pharmacy
- Retail Pharmacy
Patent Ductus Arteriosus Treatment Market Regional Analysis/Insights
The patent ductus arteriosus treatment market is analyzed and market size insights and trends are provided by diagnosis, treatment, distribution channel and end-user as referenced above.
The major countries covered in the patent ductus arteriosus treatment market report are the U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
Asia-Pacific is expected to have the highest market growth due to increased new research and developments on patent ductus arteriosus treatment market.
North America dominates the market due to the presence of key manufacturers of the product is high and, increasing research and development activities.
The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.
Competitive Landscape and Global Patent Ductus Arteriosus Treatment Market Share Analysis
The patent ductus arteriosus treatment marketcompetitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to patent ductus arteriosus treatment market
Key players operating in the patent ductus arteriosus treatment marketinclude:
- Merck & Co., Inc.(U.S.)
- AstraZeneca (U.K.)
- KYOWA PHARMA CHEMICAL CO.,LTD. (Japan)
- Sanofi (France)
- GSK plc (U.K.)
- Johnson & Johnson Private Limited (U.S.)
- Pfizer Inc (U.S.)
SKU-